# Trade Mark Journal No.2025/037 12 September 2025

## WO0000001872393 (5)

Office of origin: United States of America

Date of International Registration:15 July 2025
Date of designation in the UK: 15 July 2025

International priority date claimed: 15 January 2025 (United States of America) (98964211)

Class 5
  Pharmaceutical and biologic preparations for the prevention and treatment of organ rejection.

Stellon Biotech Inc.

Representative: Hillary Maynard Polsinelli PC, PO Box 140310, Kansas City MO 64114-0310, UNITED STATES OF AMERICA